NVST
Price
$20.24
Change
+$0.15 (+0.75%)
Updated
Aug 8 closing price
Capitalization
3.36B
79 days until earnings call
SHC
Price
$13.97
Change
+$2.75 (+24.51%)
Updated
Aug 8 closing price
Capitalization
3.97B
86 days until earnings call
Interact to see
Advertisement

NVST vs SHC

Header iconNVST vs SHC Comparison
Open Charts NVST vs SHCBanner chart's image
Envista Holdings
Price$20.24
Change+$0.15 (+0.75%)
Volume$1.7M
Capitalization3.36B
Sotera Health
Price$13.97
Change+$2.75 (+24.51%)
Volume$4.34M
Capitalization3.97B
NVST vs SHC Comparison Chart in %
Loading...
NVST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NVST vs. SHC commentary
Aug 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NVST is a Hold and SHC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 11, 2025
Stock price -- (NVST: $20.24 vs. SHC: $13.97)
Brand notoriety: NVST and SHC are both not notable
NVST represents the Pharmaceuticals: Other, while SHC is part of the Medical Specialties industry
Current volume relative to the 65-day Moving Average: NVST: 83% vs. SHC: 333%
Market capitalization -- NVST: $3.36B vs. SHC: $3.97B
NVST [@Pharmaceuticals: Other] is valued at $3.36B. SHC’s [@Medical Specialties] market capitalization is $3.97B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $168.51B to $0. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.79B. The average market capitalization across the [@Medical Specialties] industry is $9.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NVST’s FA Score shows that 0 FA rating(s) are green whileSHC’s FA Score has 1 green FA rating(s).

  • NVST’s FA Score: 0 green, 5 red.
  • SHC’s FA Score: 1 green, 4 red.
According to our system of comparison, SHC is a better buy in the long-term than NVST.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NVST’s TA Score shows that 6 TA indicator(s) are bullish while SHC’s TA Score has 7 bullish TA indicator(s).

  • NVST’s TA Score: 6 bullish, 4 bearish.
  • SHC’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, SHC is a better buy in the short-term than NVST.

Price Growth

NVST (@Pharmaceuticals: Other) experienced а +7.15% price change this week, while SHC (@Medical Specialties) price change was +25.29% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.21%. For the same industry, the average monthly price growth was -3.03%, and the average quarterly price growth was +3.24%.

The average weekly price growth across all stocks in the @Medical Specialties industry was +3.89%. For the same industry, the average monthly price growth was +1.53%, and the average quarterly price growth was -1.82%.

Reported Earning Dates

NVST is expected to report earnings on Oct 29, 2025.

SHC is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+2.21% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical Specialties (+3.89% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SHC($3.97B) has a higher market cap than NVST($3.36B). SHC has higher P/E ratio than NVST: SHC (155.22) vs NVST (63.25). NVST YTD gains are higher at: 4.925 vs. SHC (2.120). SHC has higher annual earnings (EBITDA): 416M vs. NVST (303M). NVST has more cash in the bank: 1.11B vs. SHC (304M). NVST has less debt than SHC: NVST (1.6B) vs SHC (2.35B). NVST has higher revenues than SHC: NVST (2.55B) vs SHC (1.11B).
NVSTSHCNVST / SHC
Capitalization3.36B3.97B85%
EBITDA303M416M73%
Gain YTD4.9252.120232%
P/E Ratio63.25155.2241%
Revenue2.55B1.11B231%
Total Cash1.11B304M365%
Total Debt1.6B2.35B68%
FUNDAMENTALS RATINGS
NVST: Fundamental Ratings
NVST
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
90
PRICE GROWTH RATING
1..100
50
P/E GROWTH RATING
1..100
54
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NVSTSHC
RSI
ODDS (%)
Bearish Trend 6 days ago
56%
Bearish Trend 4 days ago
61%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
67%
Bullish Trend 4 days ago
67%
Momentum
ODDS (%)
Bearish Trend 4 days ago
66%
Bullish Trend 4 days ago
71%
MACD
ODDS (%)
Bearish Trend 4 days ago
66%
Bullish Trend 4 days ago
61%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
68%
Bullish Trend 4 days ago
63%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
70%
Bullish Trend 4 days ago
58%
Advances
ODDS (%)
Bullish Trend 4 days ago
67%
Bullish Trend 4 days ago
65%
Declines
ODDS (%)
Bearish Trend 6 days ago
70%
Bearish Trend 6 days ago
73%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
55%
Bearish Trend 4 days ago
67%
Aroon
ODDS (%)
Bullish Trend 4 days ago
72%
Bullish Trend 4 days ago
72%
View a ticker or compare two or three
Interact to see
Advertisement
NVST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OANGX36.140.25
+0.70%
Oakmark Global Institutional
RNWBX85.40-0.01
-0.01%
American Funds New World R2
RSEGX53.58-0.27
-0.50%
Victory RS Small Cap Growth A
GGICX13.12-0.07
-0.53%
Goldman Sachs Global Infras C
CIPMX22.70-0.26
-1.13%
Champlain Mid Cap Adv

NVST and

Correlation & Price change

A.I.dvisor indicates that over the last year, NVST has been loosely correlated with A. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if NVST jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVST
1D Price
Change %
NVST100%
+0.75%
A - NVST
57%
Loosely correlated
+0.56%
MTD - NVST
56%
Loosely correlated
+1.54%
XRAY - NVST
54%
Loosely correlated
-2.04%
BIO - NVST
53%
Loosely correlated
-0.40%
RVTY - NVST
52%
Loosely correlated
+0.44%
More

SHC and

Correlation & Price change

A.I.dvisor indicates that over the last year, SHC has been loosely correlated with AZTA. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if SHC jumps, then AZTA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SHC
1D Price
Change %
SHC100%
+24.51%
AZTA - SHC
48%
Loosely correlated
-0.34%
RVTY - SHC
48%
Loosely correlated
+0.44%
CNMD - SHC
47%
Loosely correlated
+2.42%
A - SHC
47%
Loosely correlated
+0.56%
NVST - SHC
46%
Loosely correlated
+0.75%
More